المؤلفون: Gebrael G; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Hage Chehade C; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Sayegh N; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA., Tripathi N; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Chigarira B; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Goel D; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Nordblad B; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., McFarland TR; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Narang A; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Srivastava A; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Tandar C; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Dal E; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Jo Y; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Galarza Fortuna G; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Mathew Thomas V; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Sahu KK; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Li H; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Cancer Center, Westwood, Kansas, USA., Maughan BL; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Swami U; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Agarwal N; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

المصدر: The Prostate [Prostate] 2024 Jun; Vol. 84 (9), pp. 888-892. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/mortality , Androgen Antagonists*/therapeutic use , Androgen Antagonists*/administration & dosage, Male ; Humans ; Retrospective Studies ; Aged ; Middle Aged ; Docetaxel/therapeutic use ; Docetaxel/administration & dosage ; Neoplasm Metastasis ; Aged, 80 and over ; Progression-Free Survival ; Disease Progression

المؤلفون: Dwina Y; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.; Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Zaid LSM; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Saraswati M; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Rachmadi L; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Kekalih A; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Rahadiani N; Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Louisa M; Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Agustina H; Department of Anatomical Pathology, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin General Hospital, Bandung, Indonesia., Mochtar CA; Department of Urology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia., Hamid ARAH; Department of Urology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

المصدر: The Prostate [Prostate] 2024 Jun; Vol. 84 (8), pp. 738-746. Date of Electronic Publication: 2024 Mar 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE

مواضيع طبية MeSH: Hyaluronan Receptors*/metabolism , Hyaluronan Receptors*/analysis , Hyaluronan Receptors*/biosynthesis , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/metabolism , AC133 Antigen*/metabolism , Androgen Antagonists*/therapeutic use , Biomarkers, Tumor*/metabolism, Humans ; Male ; Retrospective Studies ; Aged ; Prognosis ; Case-Control Studies ; Middle Aged ; Aged, 80 and over ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology

المؤلفون: Nagahara A; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Urology, Osaka International Cancer Institute, Osaka, Japan., Uemura M; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Urology, Fukushima Medical University, Fukushima, Japan.; Department of Urology, Iwase General Hospital, Sukagawa, Fukushima, Japan., Sato M; Department of Urology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan., Nakata W; Department of Urology, Osaka Rosai Hospital, Sakai, Osaka, Japan., Tsujihata M; Department of Urology, Osaka Rosai Hospital, Sakai, Osaka, Japan., Takao T; Department of Urology, Osaka General Medical Center, Osaka, Japan., Matsumura S; Department of Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan., Nishimura K; Department of Urology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Takada S; Department of Urology, Osaka Police Hospital, Osaka, Japan., Iwanishi T; Department of Urology, Sakai City Medical Center, Sakai, Osaka, Japan., Kobayashi Y; Department of Urology, Kinki Central Hospital of Mutual Aid Association of Public School Teachers, Itami, Hyogo, Japan., Ishizuya Y; Department of Urology, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan., Takada T; Department of Urology, Minoh City Hospital, Minoh, Osaka, Japan., Okada K; Department of Urology, Sumitomo Hospital, Osaka, Japan., Inoue H; Department of Urology, Ikeda City Hospital, Ikeda, Osaka, Japan., Kato T; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Hatano K; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Kawashima A; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Ujike T; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Fujita K; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan., Nonomura N; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 May 07; Vol. 54 (5), pp. 584-591.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Phenylthiohydantoin*/administration & dosage , Phenylthiohydantoin*/adverse effects , Phenylthiohydantoin*/therapeutic use , Nitriles*/administration & dosage , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/blood , Benzamides* , Androgen Antagonists*/administration & dosage , Androgen Antagonists*/adverse effects, Humans ; Male ; Aged ; Prospective Studies ; Aged, 80 and over ; Middle Aged ; Tosyl Compounds/administration & dosage ; Tosyl Compounds/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Flutamide/administration & dosage ; Treatment Outcome ; Anilides/administration & dosage ; Anilides/adverse effects ; Prostate-Specific Antigen/blood

المؤلفون: Garousi M; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Mousavi Darzikolaee N; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Radiation Oncology, Imam Khomeini Hospital Complex, School of medicine, Tehran University of Medical Sciences, Tehran, Iran., Faridfar A; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran., Javadi SM; General Surgery Department, Hamadan University of Medical Sciences, Hamadan, Iran., Samizadeh E; Department of pathology, School of medicine AND Imam Reza Hospital, AJA University of Medical Sciences, Tehran, Iran., Sajadi Rad M; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Bayani R; Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Radiation Oncology, Imam Khomeini Hospital Complex, School of medicine, Tehran University of Medical Sciences, Tehran, Iran.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Apr; Vol. 7 (4), pp. e2041.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists* , Prostatic Neoplasms, Castration-Resistant*, Male ; Humans ; Middle Aged ; Docetaxel ; Bone Marrow/pathology ; Treatment Outcome

المؤلفون: Ventimiglia E; Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Gedeborg R; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Medical Products Agency, Uppsala, Sweden., Styrke J; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Robinson D; Department of Urology, Umeå University, Region of Jönköping, Sweden., Stattin P; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Garmo H; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

المصدر: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2414599. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Watchful Waiting*/statistics & numerical data , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/mortality , Prostatic Neoplasms*/pathology , Androgen Antagonists*/therapeutic use, Humans ; Male ; Aged ; Sweden/epidemiology ; Aged, 80 and over ; Cohort Studies ; Life Expectancy ; Registries ; Prostatic Neoplasms, Castration-Resistant/therapy ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Disease Progression

المؤلفون: Owa S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Sasaki T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Ikadai R; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Tabata Y; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Takeuchi Y; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Nishikawa T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Kato M; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Higashi S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Sugino Y; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Masui S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Nishikawa K; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan., Inoue T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan. tinoue28@med.mie-u.ac.jp.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2024 Jun; Vol. 29 (6), pp. 840-846. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Psoas Muscles*/diagnostic imaging , Psoas Muscles*/pathology , Lumbar Vertebrae*/diagnostic imaging , Tomography, X-Ray Computed* , Androgen Antagonists*/therapeutic use, Humans ; Male ; Aged ; Retrospective Studies ; Middle Aged ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Aged, 80 and over ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/drug therapy

المؤلفون: Grisay G; Department of Medical Oncology, Centres Hospitaliers Universitaires Helora, La Louvière, Belgium. g.grisay@gmail.com., Lavaud P; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.

المصدر: Current oncology reports [Curr Oncol Rep] 2024 May; Vol. 26 (5), pp. 488-495. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists*/therapeutic use, Humans ; Male ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/therapy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Prostatic Neoplasms/drug therapy ; Neoplasm Metastasis ; Docetaxel/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Androgen Receptor Antagonists/therapeutic use

المؤلفون: Wang Y; Department of Urology, Second Hospital of Tianjin Medical University, Tianjin, China., Liu C; Department of Urology, Zhujiang Hospital of Southern Medical University, Guangzhou City, China., Liu C; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China., Lu Y; Health Economics and Outcomes Research, Astellas Pharma, Shanghai, China., Ban L; Evidera, PPD, Beijing, China., Niu Y; Department of Urology, Second Hospital of Tianjin Medical University, Tianjin, China.

المصدر: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 361-369. Date of Electronic Publication: 2024 Mar 11.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists*/therapeutic use , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Anilides* , Nitriles* , Tosyl Compounds*, Male ; Humans ; Retrospective Studies ; Androgens/therapeutic use ; Delivery of Health Care

المؤلفون: Ojeda-Claro AV; Unidad de Uro-Oncología, Hospital Universitario Puerta del Mar, Cádiz, Spain. Electronic address: anavictoriaojeda.1@gmail.com., Ledo-Cepero MJ; Unidad de Uro-Oncología, Hospital Universitario Puerta del Mar, Cádiz, Spain., Álvarez-Ossorio JL; Unidad de Uro-Oncología, Hospital Universitario Puerta del Mar, Cádiz, Spain.

المصدر: Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2023 Nov; Vol. 47 (9), pp. 543-545. Date of Electronic Publication: 2023 Apr 23.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101771154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5786 (Electronic) Linking ISSN: 21735786 NLM ISO Abbreviation: Actas Urol Esp (Engl Ed) Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists*/therapeutic use , Prostatic Neoplasms, Castration-Resistant*, Male ; Humans ; Retrospective Studies

المؤلفون: Paolieri F; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Sammarco E; Medical Oncology Unit, Livorno Hospital, Azienda Toscana Nord Ovest, Livorno, Italy., Ferrari M; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Salfi A; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Bonato A; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Serafin D; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Coccia N; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Manfredi F; Medical Oncology Unit, Sant'Andrea Hospital, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy., Zatteri L; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Dima G; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Carli C; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Di Vita R; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Oliveri M; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Doni L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy., Galli L; Medical Oncology Unit 2, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Sisani M; Medical Oncology Unit, San Donato Hospital, Azienda Toscana Sud Est, Arezzo, Italy., Catalano M; Department of Health Sciences, University of Florence, Florence, Italy. Electronic address: martina.catalano@unifi.it., Roviello G; Department of Health Sciences, University of Florence, Florence, Italy., Bloise F; Medical Oncology Unit, San Donato Hospital, Azienda Toscana Sud Est, Arezzo, Italy.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Aug; Vol. 22 (4), pp. 102096. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms* , Androgen Antagonists*/therapeutic use, Humans ; Male ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Gonadotropin-Releasing Hormone/agonists ; Neoplasm Metastasis